jflahiff.wordpress.com
Challenges to FDA’s Ability To Monitor and Inspect Foreign Clinical Trials
In fiscal year 2008, 80 percent of approved marketing applications for drugs and biologics contained data from foreign clinical trials. Over half of clinical trial subjects and sites were located …